Prime Medicine Inc. (PRME) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Prime Medicine Inc.

NASDAQ: PRME · Real-Time Price · USD
3.72
0.32 (9.41%)
At close: Sep 05, 2025, 3:59 PM
3.80
2.15%
After-hours: Sep 05, 2025, 07:55 PM EDT

Prime Medicine Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.98M n/a n/a n/a
Cost of Revenue
n/a 4.65M 12.01M 4.86M
Gross Profit
2.98M -4.65M -12.01M -4.86M
Operating Income
-202.47M -191.29M -116.54M -84.47M
Interest Income
3.52M n/a n/a n/a
Pretax Income
-195.88M -198.41M -122.77M -165.85M
Net Income
-195.88M -198.13M -121.82M -165.37M
Selling & General & Admin
50.16M 38.73M 29.82M 13.92M
Research & Development
155.29M 147.91M 86.72M 70.55M
Other Expenses
n/a -129.75M n/a n/a
Operating Expenses
205.45M 56.89M 116.54M 84.47M
Interest Expense
n/a n/a 12.13M n/a
Selling & Marketing Expenses
n/a -4.65M n/a n/a
Cost & Expenses
205.45M 204.79M 116.54M 84.47M
Income Tax Expense
n/a -279K -948K -486K
Shares Outstanding (Basic)
118.6M 90.97M 97.21M 64.9M
Shares Outstanding (Diluted)
118.6M 90.97M 97.21M 64.9M
EPS (Basic)
-1.65 -2.18 -1.46 -2.56
EPS (Diluted)
-1.65 -2.18 -1.46 -2.56
EBITDA
-196.34M -193.76M -110.75M -160.99M
EBIT
-202.47M -198.41M -122.77M -165.85M
Depreciation & Amortization
6.13M 4.65M 12.01M 4.86M